Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: BiGx who wrote (4299)	7/13/1998 10:06:00 PM
From: Cosmo Daisey	Read Replies (1) \| Respond to of 9523

BiGx, The next twelve months will bring more approvals for viagra in europe and other countries. The earnings potential of one drug doesn't make PFE the stock of the decade however but the pipeline is solid with several new compounds nearing approval. The short term volatility of the stock means opportunities for daytraders and short term holders but the long term outlook is secure based on earnings and sector appeal. I hold a core position and trade short term also. Even sloppy timing will return a profit because of the positive bias of the trading trend, or in other words if you pay too much don't worry, in a few days you will be whole again. This is not to say there won't be pull backs but the long term outlook is secure. Coz

To: BiGx who wrote (4299)	7/13/1998 10:18:00 PM
From: Anthony Wong	Read Replies (2) \| Respond to of 9523

Welcome aboard, BiGx. I am not the best person to answer your question because I'm a big PFE bull. I still consider PFE a good long trm hold (and a buy whenever it dips 10%-15%) because, similar to great companies such as KO, GE, PG, CSCO and LU, it justifies a high P/E. As many in this thread has stressed, PFE is more than Viagra. Even if Viagra is recalled by the FDA (which I think is highly unlikely) and the stock drops to $75, it would eventually work its way up again because there are other potential blockbusters such as Celebra coming and the other blockbuster drugs continue to gain market share. If you feel that PFE would be vulnerable and you want to protect your profit, perhaps you can consider writing covered calls.